Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 183 entries
View as:

The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT05813561 Org: User:
Start: 12/30/21 End: 02/17/23 Due: 02/17/24

A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients with Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT06671392 Org: User:
Start: 02/24/25 End: 12/31/26 Due: 12/31/27

Nurigra Chewable Tablet in Healthy Adult Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01651858 Org: User:
Start: 02/29/12 End: 03/31/12 Due: 03/31/13

Clinical Trial to Investigate the Efficacy and Safety of DWJ1351

Phase: N/A Priority: Normal
NCT ID: NCT03753477 Org: User:
Start: 12/22/17 End: 02/01/18 Due: 02/01/19

Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03947489 Org: User:
Start: 03/04/19 End: 05/06/19 Due: 05/06/20

Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)

Phase: N/A Priority: Normal
NCT ID: NCT03184363 Org: User:
Start: 07/31/17 End: 12/31/17 Due: 12/31/18

Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients

Phase: N/A Priority: Normal
NCT ID: NCT04713176 Org: User:
Start: 02/02/21 End: 12/09/22 Due: 12/09/23

to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection

Phase: N/A Priority: Normal
NCT ID: NCT06437951 Org: User:
Start: 07/31/24 End: 05/31/25 Due: 05/31/26

Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05149274 Org: User:
Start: 10/01/21 End: 10/26/21 Due: 10/26/22

Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir

Phase: N/A Priority: Normal
NCT ID: NCT06000657 Org: User:
Start: 08/28/23 End: 02/03/25 Due: 02/03/26

The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT04654390 Org: User:
Start: 12/30/20 End: 12/17/21 Due: 12/17/22

Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03947528 Org: User:
Start: 03/04/19 End: 05/13/19 Due: 05/13/20

Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT06647888 Org: User:
Start: 12/03/24 End: 06/30/26 Due: 06/30/27

Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT03009721 Org: User:
Start: 08/31/16 End: 06/30/18 Due: 06/30/19

Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02952547 Org: User:
Start: 10/30/16 End: 01/10/17 Due: 01/10/18

Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines

Phase: N/A Priority: Normal
NCT ID: NCT07013279 Org: User:
Start: 07/15/25 End: 03/31/26 Due: 03/31/27

Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT05614778 Org: User:
Start: 02/28/22 End: 05/31/24 Due: 05/31/25

To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis

Phase: N/A Priority: Normal
NCT ID: NCT06668506 Org: User:
Start: 03/17/22 End: 03/13/24 Due: 03/13/25

Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02947139 Org: User:
Start: 09/29/16 End: 11/02/16 Due: 11/02/17

Comparative Bioavailability Study of UDCA

Phase: N/A Priority: Normal
NCT ID: NCT02385032 Org: User:
Start: 02/28/15 End: 05/31/15 Due: 05/31/16

A Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Combination of Rosuvastatin and CS-866 and DWJ1276

Phase: N/A Priority: Normal
NCT ID: NCT01493856 Org: User:
Start: 01/31/12 End: 03/31/12 Due: 03/31/13

Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT06419816 Org: User:
Start: 06/11/24 End: 06/30/26 Due: 06/30/27

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06119945 Org: User:
Start: 11/09/23 End: 12/31/23 Due: 12/31/24

Treatment Effect According to Timing of Administration of DWP14012 40 mg

Phase: N/A Priority: Normal
NCT ID: NCT04613895 Org: User:
Start: 11/17/20 End: 12/30/21 Due: 12/30/22

Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01964365 Org: User:
Start: 09/30/13 End: 12/31/13 Due: 12/31/14